Related Experiment Video
Updated: Jul 19, 2026
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Mitochondrial DNA polymerase-gamma and human disease
Gavin Hudson1, Patrick F Chinnery
1Mitochondrial Research Group and Institute of Human Genetics, M41014, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Abstract:
The maintenance of mitochondrial DNA (mtDNA) is critically dependent upon polymerase-gamma (pol-gamma), encoded by the nuclear gene POLG. Over the last 5 years, it has become clear that mutations of POLG are a major cause of human disease. Secondary mtDNA defects characterize these disorders, with mtDNA depletion, multiple mtDNA deletions or multiple point mutations of mtDNA in clinically affected tissues. The secondary mtDNA defects cause cell and tissue-specific deficiencies of mitochondrial oxidative phosphorylation, leading to organ dysfunction and human disease. Functional genetic variants of POLG are present in up to approximately 0.5% of the general population, and pathogenic mutations have been described in most exons of the gene. Clinically, POLG mutations can present from early neonatal life to late middle age, with a spectrum of phenotypes that includes common neurological disorders such as migraine, epilepsy and Parkinsonism. Transgenic mice and biochemical studies of recombinant mutated proteins are helping to unravel mechanisms of pathogenesis, and patterns are beginning to emerge relating genotype to phenotype.
Insights
Mutations in the POLG gene, which codes for polymerase-gamma (pol-gamma), are a significant cause of human diseases. These POLG mutations lead to mitochondrial DNA defects, resulting in organ dysfunction and various neurological disorders.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- Mitochondrial DNA (mtDNA) maintenance relies on polymerase-gamma (pol-gamma), encoded by the nuclear POLG gene.
- Mutations in POLG are increasingly recognized as a primary cause of human diseases.
- These disorders are characterized by secondary mtDNA defects, including depletion, deletions, or point mutations.
Purpose of the Study:
- To elucidate the role of POLG gene mutations in human disease pathogenesis.
- To understand the mechanisms linking POLG mutations to secondary mtDNA defects and organ dysfunction.
- To explore the genotype-phenotype correlations in patients with POLG mutations.
Main Methods:
- Analysis of POLG gene mutations in affected individuals.
- Biochemical studies using recombinant mutated pol-gamma proteins.
- Development and study of transgenic mouse models.
Main Results:
- POLG mutations are a major cause of human diseases with secondary mtDNA defects.
- These defects lead to tissue-specific deficiencies in mitochondrial oxidative phosphorylation.
- POLG mutations present a wide spectrum of phenotypes, including neurological disorders like epilepsy and Parkinsonism.
- Functional genetic variants of POLG are found in up to 0.5% of the general population.
Conclusions:
- POLG mutations are a significant genetic cause of human disease, impacting mitochondrial function.
- Understanding POLG mutation mechanisms is crucial for diagnosing and potentially treating a range of debilitating conditions.
- Genotype-phenotype relationships are emerging, aiding in clinical prediction and management.
Related Concept Videos
02:59Animal Mitochondrial Genetics
01:31Proofreading
Errors During Replication are Corrected by the DNA Polymerase Enzyme
01:43Proofreading
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
02:10Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...